Published in Osteoporos Int on January 01, 1997
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Assessment of fracture risk. Osteoporos Int (2004) 5.15
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS (2000) 3.39
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62
How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician (2003) 2.42
Alcohol intake as a risk factor for fracture. Osteoporos Int (2004) 2.34
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ (2000) 1.94
Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review. Osteoporos Int (2007) 1.80
Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study. Osteoporos Int (2006) 1.75
Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis (1998) 1.72
Effects of coffee consumption and smoking habit on bone mineral density. Rheumatol Int (2005) 1.61
The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int (2004) 1.60
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J (2007) 1.51
Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med (2004) 1.50
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women. Ann Rheum Dis (2003) 1.46
Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool. J Bone Miner Res (2010) 1.42
Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int (2008) 1.39
A meta-analysis of milk intake and fracture risk: low utility for case finding. Osteoporos Int (2004) 1.39
Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int (2003) 1.39
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Osteoporosis and bone densitometry: does the emperor have clothes? CMAJ (1998) 1.29
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis. Osteoporos Int (2011) 1.28
Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25
Influence of bone densitometry results on the treatment of osteoporosis. CMAJ (2001) 1.24
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice. Clin Interv Aging (2008) 1.22
Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J (2003) 1.18
Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study. BMC Musculoskelet Disord (2005) 1.18
Patterns of use of the bone mineral density test in Ontario, 1992-1998. CMAJ (2000) 1.14
Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect (2002) 1.13
Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models. Bone (2010) 1.12
BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int (2009) 1.12
Bone matrix imaged in vivo by water- and fat-suppressed proton projection MRI (WASPI) of animal and human subjects. J Magn Reson Imaging (2010) 1.11
Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention. J Am Med Dir Assoc (2006) 1.10
Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10
Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int (2003) 1.10
Effect of prayer on osteoarthritis and osteoporosis. Rheumatol Int (2007) 1.09
Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (2004) 1.09
Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Musculoskelet Disord (2007) 1.07
The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study. Osteoporos Int (2005) 1.06
Patients' preferences for osteoporosis drug treatment: a discrete choice experiment. Osteoporos Int (2008) 1.02
Evaluation of vertebral bone marrow fat content by chemical-shift MRI in osteoporosis. Skeletal Radiol (2010) 1.01
Fracture risk and antiresorptive medication use in older women in the USA. Osteoporos Int (2007) 1.00
Intervertebral disc height loss demonstrates the threshold of major pathological changes during degeneration. Eur Spine J (2014) 0.97
A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int (2005) 0.96
A FRAX® model for the assessment of fracture probability in Belgium. Osteoporos Int (2010) 0.94
Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol (2004) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos (2016) 0.92
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int (2009) 0.92
Bone mineral imaged in vivo by 31P solid state MRI of human wrists. J Magn Reson Imaging (2011) 0.92
The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects. Osteoporos Int (2006) 0.92
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers. Br J Clin Pharmacol (2013) 0.92
Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord (2005) 0.91
Evaluation of FRAX to characterise fracture risk in Poland. Osteoporos Int (2010) 0.90
Relationship between Weight, Body Mass Index and Bone Mineral Density of Lumbar Spine in Women. J Bone Metab (2012) 0.89
High bone mineral density among perimenopausal women. Osteoporos Int (2005) 0.89
Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry. Osteoporos Int (2004) 0.89
Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol (2006) 0.89
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). Osteoporos Int (2003) 0.89
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Vertebral fracture risk and alendronate effects on osteoporosis assessed by a computed tomography-based nonlinear finite element method. J Bone Miner Metab (2011) 0.88
Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials. Int J Endocrinol (2013) 0.88
Case-finding for adult celiac disease in patients with reduced bone mineral density. Dig Dis Sci (2005) 0.88
Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis. Osteoporos Int (2010) 0.88
Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia. Rheumatol Int (2012) 0.87
Approaches to the targeting of treatment for osteoporosis. Nat Rev Rheumatol (2009) 0.87
Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography. Osteoporos Int (2004) 0.87
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. Osteoporos Int (2009) 0.86
Phytonutrients for bone health during ageing. Br J Clin Pharmacol (2013) 0.86
Follow-up treatment for osteoporosis after fracture. Osteoporos Int (2004) 0.86
Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review. Osteoporos Int (2010) 0.86
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling. PPAR Res (2011) 0.85
Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis? Curr Opin Pharmacol (2014) 0.85
Awareness of osteoporosis among physicians in China. Osteoporos Int (2004) 0.85
Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives. Clin Interv Aging (2015) 0.84
Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health (2015) 0.84
Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop (2016) 0.84
Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep (2008) 0.84
Bone mineral density changes in relation to environmental PCB exposure. Environ Health Perspect (2008) 0.83
Smokeless tobacco use accelerates age-related loss of bone mineral density among older women in a multi-ethnic rural community. J Cross Cult Gerontol (2005) 0.83
An osteoporosis screening tool for Chinese men. Osteoporos Int (2004) 0.83
Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound. BMC Womens Health (2010) 0.82
Bone loss. Epidemiology of bone loss. Arthritis Res (2000) 0.82
Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int (2005) 0.82
The effect of calcitonin on beta-endorphin levels in postmenopausal osteoporotic patients with back pain. Clin Rheumatol (2006) 0.82
A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporos Int (2012) 0.81
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Arch Public Health (2015) 0.81
Identifying osteoporosis in a primary care setting with quantitative ultrasound: relationship to anthropometric and lifestyle factors. J Bone Miner Metab (2007) 0.81
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. Eur J Clin Pharmacol (2009) 0.80
Metacarpal index and bone mineral density in healthy African-American women. Osteoporos Int (2005) 0.80
Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted? Osteoporos Int (2012) 0.79
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18
Bone density screening for osteoporosis. Lancet (1990) 3.87
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences. BMJ (1999) 2.94
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol (1998) 2.73
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci (2001) 2.52
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res (2000) 2.32
Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
How should we pay doctors? A systematic review of salary payments and their effect on doctor behaviour. QJM (1999) 2.26
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23
Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22
Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19
Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health (1992) 2.11
The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) (2005) 2.11
Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci (2000) 2.04
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Are rates of ageing determined in utero? Age Ageing (1998) 1.95
Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95
Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing (1989) 1.94
Collaborative care for depression in UK primary care: a randomized controlled trial. Psychol Med (2007) 1.90
Radiographic assessment of osteoarthritis in population studies: whither Kellgren and Lawrence? Osteoarthritis Cartilage (1993) 1.88
Studies on the role of the morphological constituents of the microsome fraction from rat liver in protein synthesis. Biochem J (1964) 1.86
Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol (1998) 1.85
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ (1988) 1.83
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Clinical risk factors, bone density and fall history in the prediction of incident fracture among men and women. Bone (2012) 1.82
Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res (2001) 1.82
Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (2013) 1.81
Osteoporosis, falls, and age in fracture of the proximal femur. Br Med J (Clin Res Ed) (1987) 1.81
Rectal spirochaetosis in homosexual men: characterisation of the organism and pathophysiology. Genitourin Med (1986) 1.79
Incidence of distal forearm fracture in British men and women. Osteoporos Int (2001) 1.79
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. Br J Cancer (2009) 1.77
Intrauterine programming of adult body composition. J Clin Endocrinol Metab (2001) 1.76
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76